CRISPR screens are feasible in TP53 wild-type cells.

ABSTRACT: A recent study by Haapaniemi et al (2018) reported that intact p53 signaling hampers CRISPR-based functional genomic screens. Brown et al report good performance of genome-scale screens in TP53 wild-type cells and reiterate best practices for CRISPR screening.

SUBMITTER: Brown KR 

PROVIDER: S-EPMC6686785 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature